Capitalisation Boursière Changement Date
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Cytokinetics USD 9.25B 1.48B 2026-05
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 148.08B 6.51B 2026-05
PTC Therapeutics USD 6.1B 1.22B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05
Xencor USD 1.09B 256M 2025-12